John A. Kollins

Insider Reports History

Entity
Individual
Location
Satsuma Pharmaceuticals, Inc., 400 Oyster Point Boulevard, Suite 221, South San Francisco, CA
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for John A. Kollins
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Kollins:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Satsuma Pharmaceuticals, Inc. President and CEO, Director Common Stock, $0.0001 par value 0 $0.91 Jun 6, 2023 Direct
Satsuma Pharmaceuticals, Inc. President and CEO, Director Stock Option (right to buy) 0 Jun 8, 2023 Direct

Insider Reports Filed by John A. Kollins

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STSA Satsuma Pharmaceuticals, Inc. Jun 6, 2023 8 -$278K 4 Jun 8, 2023 President and CEO, Director
STSA Satsuma Pharmaceuticals, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 President and CEO, Director